144 related articles for article (PubMed ID: 36082822)
1. High expression of PDIA4 promotes malignant cell behavior and predicts reduced survival in cervical cancer.
Xing F; Song Z; Cheng Z
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36082822
[TBL] [Abstract][Full Text] [Related]
2. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway.
Tao J; Xue C; Cao M; Ye J; Sun Y; Chen H; Guan Y; Zhang W; Zhang W; Yao Y
Breast Cancer Res; 2024 Jan; 26(1):1. PubMed ID: 38167446
[TBL] [Abstract][Full Text] [Related]
3. Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy.
Tu Z; Wang C; Hu Q; Tao C; Fang Z; Lin L; Lei K; Luo M; Sheng Y; Long X; Li J; Wu L; Huang K; Zhu X
J Exp Clin Cancer Res; 2023 Mar; 42(1):77. PubMed ID: 36997943
[TBL] [Abstract][Full Text] [Related]
4. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
Qian S; Zhang S; Wu Y; Ding Y; ; Li X
Chemotherapy; 2020; 65(5-6):125-133. PubMed ID: 33238278
[TBL] [Abstract][Full Text] [Related]
5. Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1α and protein disulfide isomerase suppresses the progression of cervical cancer.
Zhang Y; Li T; Zhang L; Shangguan F; Shi G; Wu X; Cui Y; Wang X; Wang X; Liu Y; Lu B; Wei T; Wang CC; Wang L
EBioMedicine; 2019 Mar; 41():408-419. PubMed ID: 30826359
[TBL] [Abstract][Full Text] [Related]
6. Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway.
Kuo TF; Chen TY; Jiang ST; Chen KW; Chiang YM; Hsu YJ; Liu YJ; Chen HM; Yokoyama KK; Tsai KC; Yeh HH; Chen YR; Yang MT; Yang CY; Yang WC
Oncogene; 2017 Sep; 36(39):5484-5496. PubMed ID: 28534513
[TBL] [Abstract][Full Text] [Related]
7. Effect of the disulfide isomerase PDIa4 on the antibody production of Chinese hamster ovary cells.
Komatsu K; Kumon K; Arita M; Onitsuka M; Omasa T; Yohda M
J Biosci Bioeng; 2020 Dec; 130(6):637-643. PubMed ID: 32878739
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-378a-3p contributes to ovarian cancer progression through downregulating PDIA4.
Chanjiao Y; Chunyan C; Xiaoxin Q; Youjian H
Immun Inflamm Dis; 2021 Mar; 9(1):108-119. PubMed ID: 33159506
[TBL] [Abstract][Full Text] [Related]
9. PDIA4 confers resistance to ferroptosis via induction of ATF4/SLC7A11 in renal cell carcinoma.
Kang L; Wang D; Shen T; Liu X; Dai B; Zhou D; Shen H; Gong J; Li G; Hu Y; Wang P; Mi X; Zhang Y; Tan X
Cell Death Dis; 2023 Mar; 14(3):193. PubMed ID: 36906674
[TBL] [Abstract][Full Text] [Related]
10. Protein disulfide isomerase a4 promotes lung cancer development via the Stat3 pathway in stromal cells.
Chen TY; Yang CY; Yang MT; Kuo TF; Chang CL; Chen CL; Lee TH; Yang G; Yang WC; Chiu CF; Yu AY
Clin Transl Med; 2022 Feb; 12(2):e606. PubMed ID: 35170261
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.
Karatas E; Raymond AA; Leon C; Dupuy JW; Di-Tommaso S; Senant N; Collardeau-Frachon S; Ruiz M; Lachaux A; Saltel F; Bouchecareilh M
JHEP Rep; 2021 Aug; 3(4):100297. PubMed ID: 34151245
[TBL] [Abstract][Full Text] [Related]
12. PDIA4: The basic characteristics, functions and its potential connection with cancer.
Wang Z; Zhang H; Cheng Q
Biomed Pharmacother; 2020 Feb; 122():109688. PubMed ID: 31794946
[TBL] [Abstract][Full Text] [Related]
13. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
14. Association of protein disulfide isomerase family A, member 4, and inflammation in people living with HIV.
Wang NC; Chen HW; Lin TY
Int J Infect Dis; 2023 Jan; 126():79-86. PubMed ID: 36375691
[TBL] [Abstract][Full Text] [Related]
15. Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer.
Yin F; Yi S; Wei L; Zhao B; Li J; Cai X; Dong C; Liu X
J Cell Biochem; 2019 Apr; 120(4):6057-6070. PubMed ID: 30335894
[TBL] [Abstract][Full Text] [Related]
16. PDIA4, a new endoplasmic reticulum stress protein, modulates insulin resistance and inflammation in skeletal muscle.
Lee CH; Chiang CF; Lin FH; Kuo FC; Su SC; Huang CL; Li PF; Liu JS; Lu CH; Hsieh CH; Hung YJ; Shieh YS
Front Endocrinol (Lausanne); 2022; 13():1053882. PubMed ID: 36619574
[TBL] [Abstract][Full Text] [Related]
17. Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
He JH; Chen JG; Zhang B; Chen J; You KL; Hu JM; Xu JW; Chen L
Technol Cancer Res Treat; 2020; 19():1533033820936773. PubMed ID: 32618228
[TBL] [Abstract][Full Text] [Related]
18. PDIA4 promotes glioblastoma progression via the PI3K/AKT/m-TOR pathway.
Wang M; Zhang W; Liu Y; Ma Z; Xiang W; Wen Y; Zhang D; Li Y; Li Y; Li T; Chen L; Zhou J
Biochem Biophys Res Commun; 2022 Mar; 597():83-90. PubMed ID: 35131603
[TBL] [Abstract][Full Text] [Related]
19. Family with sequence similarity 83 member A promotes tumor cell proliferation and metastasis and predicts poor prognosis in cervical cancer.
Liu T; Chen J; Du Q; Liu J; Chen M; Ooi S; Huang J; Wang W; Yao S
Pathol Res Pract; 2021 Jun; 222():153450. PubMed ID: 33962175
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of BRCC3 exerts an anti‑tumor effect on cervical cancer in vitro.
Zhang F; Zhou Q
Mol Med Rep; 2018 Dec; 18(6):4886-4894. PubMed ID: 30272359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
